Schrodinger Expands its Drug Discovery Efforts Against COVID-19 Deploying Parallel Computing on Google Cloud

 Schrodinger Expands its Drug Discovery Efforts Against COVID-19 Deploying Parallel Computing on Google Cloud

Schrödinger Expands its Drug Discovery Efforts Against COVID-19 Deploying Parallel Computing on Google Cloud

Shots:

  • Schrodinger expands its work to discover novel antiviral therapies for COVID-19 as a part of a philanthropic global initiative. The accelerated pace includes the evaluation of billions of molecules/ week and is supported by Google Cloud which provides its high-powered parallel computing enabling the rapid exploration of chemical space
  • Schrodinger has evaluated four different protein targets for the COVID-19 initiative and utilized Google Cloud to support ultra-large virtual screens for two targets
  • In early 2020, the two companies collaborated, providing Schrodinger access to computing capacity equivalent to the world’s most powerful supercomputers to accelerate discovery for its commercial partners and its internal pipeline

Click here to read full press release/ article | Ref: Business wire | Image: Fierce Biotech

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post